An oral small molecule from New York-based biotech Oligomerix curbed the tangling of tau protein in the brains of mice that ...

The winners will receive a cash contribution of €25,000 for the first prize winner, €15,000 for the second prize winner, ...

India’s rental landscape is fast evolving, with Tier 2 and 3 cities emerging as hotspots for growing housing demand. As ...

Kolkata: A man, who repeatedly took a second-hand sedan car on test drives, allegedly stole the vehicle from a used-car ...

A car drove into a crowd of people in the western German city of Mannheim on Monday, killing at least one person, injuring ...

Kroger said on Monday Chief Executive Officer Rodney McMullen has resigned after a board investigation found that his ...

However, it is possible to sell the note for a higher price through certain avenues, such as websites and apps like eBay and OLX. This special Rs 50 note must feature the number 786 inscribed on it, ...

OliX Pharmaceuticals, a listed company on the KOSDAQ, has been designated as an investment warning stock due to a sharp rise in its stock price, and if the stock price rises further on the 18th ...

Eli Lilly and RNAi therapeutics specialist OliX Pharmaceuticals have entered into a global licensing agreement to advance a phase 1 candidate for metabolic-associated steatohepatitis (MASH) and other ...

South Korea-based OliX Pharmaceuticals, Inc., a developer of RNAi therapeutics, entered a global licensing agreement with Eli Lilly and Co. focused on the development and commercialization of OliX’s ...

Meanwhile, Eli Lilly signed a global licensing deal for a MASH asset with South Korea’s OliX Pharmaceuticals. Speaking of controversy, Regeneron is suing its Dupixent partner Sanofi, claiming the ...

Olix Pharmaceuticals Inc. walked the talk in realizing a new $630 million licensing deal with Eli Lilly and Co. for its cardiovascular and metabolic disease asset, OLX-702A (OLX-75016), rallying stock ...